In Germany, CellForn said that manufacturing firm Albert Weber has become a new shareholder in the company. The merger will be accomplished through several incremental capital increases, the firm said. Both companies aim to leverage the potential of CellForm’s technology for hydrogen applications and Albert Weber’s expertise in industrialization by combining their competencies and resources.
Albert Weber and CellForm plan to invest double-digit millions in the coming years to establish mass production of bipolar plates. CellForm’s goal is to become one of the leading suppliers of bipolar plates and make a significant contribution to the energy transition.
“CellForm combines start-up spirit with tradition and is the disruptor of the industry in terms of technical and economic efficiency, thanks to innovative manufacturing approaches for the key component of hydrogen technology. With Weber, we have found the perfect partner to scale our technology,” says Simon Brugger, CEO of CellForm.
More on the story.
